Journal of Pediatric Neurology 2020; 18(06): 301-306
DOI: 10.1055/s-0040-1716909
Review Article

Transition of Care for Children with High-Grade Central Nervous System Tumors

Yosef Ellenbogen
1   Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
,
Kaiyun Yang
2   Division of Neurosurgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada
,
Olufemi Ajani
2   Division of Neurosurgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada
3   McMaster University Medical Center and Children's Hospital, Hamilton, Ontario, Canada
› Author Affiliations

Abstract

The increase in survival rates of children with high-grade central nervous system tumors has highlighted the necessity for and challenges associated with transition of care as these children grow into adult life. Late recurrence and treatment effects are some of the conditions that require care after transition. Several models of transition have been proposed in the literature. An effective transition will not only ensure adequate continuity of care but will also include assessment of effectiveness of the transition by health care personnel and the patient/patient's family themselves.



Publication History

Received: 10 November 2019

Accepted: 07 January 2020

Article published online:
28 September 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Smith MA, Seibel NL, Altekruse SF. et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 2010; 28 (15) 2625-2634
  • 2 Johung TB, Monje M. Diffuse intrinsic pontine glioma: new pathophysiological insights and emerging therapeutic targets. Curr Neuropharmacol 2017; 15 (01) 88-97
  • 3 Warren KE. Pediatric high-grade gliomas: survival at what cost?. Transl Pediatr 2012; 1 (02) 116-117
  • 4 Sands SA, Zhou T, O'Neil SH. et al. Long-term follow-up of children treated for high-grade gliomas: Children's Oncology Group L991 final study report. J Clin Oncol 2012; 30 (09) 943-949
  • 5 Fischer C, Petriccione M, Donzelli M, Pottenger E. Improving care in pediatric neuro-oncology patients: an overview of the unique needs of children with brain tumors. J Child Neurol 2016; 31 (04) 488-505
  • 6 Miranda Kuzan-Fischer C, Juraschka K, Taylor MD. Medulloblastoma in the molecular era. J Korean Neurosurg Soc 2018; 61 (03) 292-301
  • 7 Taylor RE, Bailey CC, Robinson KJ. et al. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer 2005; 41 (05) 727-734
  • 8 Hoff KV, Hinkes B, Gerber NU. et al. Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. Eur J Cancer 2009; 45 (07) 1209-1217
  • 9 Agerlin N, Gjerris F, Brincker H. et al. Childhood medulloblastoma in Denmark 1960-1984. A population-based retrospective study. Childs Nerv Syst 1999; 15 (01) 29-36 , discussion 36–37
  • 10 Biswas A, Kashyap L, Kakkar A, Sarkar C, Julka PK. Atypical teratoid/rhabdoid tumors: challenges and search for solutions. Cancer Manag Res 2016; 8: 115-125
  • 11 Richardson EA, Ho B, Huang A. Atypical teratoid rhabdoid tumour: from tumours to therapies. J Korean Neurosurg Soc 2018; 61 (03) 302-311
  • 12 Bartelheim K, Nemes K, Seeringer A. et al. Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007. Cancer Med 2016; 5 (08) 1765-1775
  • 13 Fangusaro J. Pediatric high grade glioma: a review and update on tumor clinical characteristics and biology. Front Oncol 2012; 2: 105
  • 14 Gopal P, Parker JR, Debski R, Parker Jr JC. Choroid plexus carcinoma. Arch Pathol Lab Med 2008; 132 (08) 1350-1354
  • 15 Mishra A, Srivastava C, Singh SK, Chandra A, Ojha BK. Choroid plexus carcinoma: case report and review of literature. J Pediatr Neurosci 2012; 7 (01) 71-73
  • 16 Dudley RWR, Torok MR, Gallegos D, Liu AK, Handler MH, Hankinson TC. Pediatric choroid plexus tumors: epidemiology, treatments, and outcome analysis on 202 children from the SEER database. J Neurooncol 2015; 121 (01) 201-207
  • 17 Berger C, Thiesse P, Lellouch-Tubiana A, Kalifa C, Pierre-Kahn A, Bouffet E. Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery 1998; 42 (03) 470-475
  • 18 Zaky W, Dhall G, Khatua S. et al. Choroid plexus carcinoma in children: the Head Start experience. Pediatr Blood Cancer 2015; 62 (05) 784-789
  • 19 Wisoff JH, Boyett JM, Berger MS. et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. J Neurosurg 1998; 89 (01) 52-59
  • 20 Kim K, Cho C, Bang MS, Shin HI, Phi JH, Kim SK. Intraoperative neurophysiological monitoring: a review of techniques used for brain tumor surgery in children. J Korean Neurosurg Soc 2018; 61 (03) 363-375
  • 21 Sala F, Coppola A, Tramontano V, Babini M, Pinna G. Intraoperative neurophysiological monitoring for the resection of brain tumors in pediatric patients. J Neurosurg Sci 2015; 59 (04) 373-382
  • 22 David KM, Casey AT, Hayward RD, Harkness WF, Phipps K, Wade AM. Medulloblastoma: is the 5-year survival rate improving? A review of 80 cases from a single institution. J Neurosurg 1997; 86 (01) 13-21
  • 23 Law N, Smith ML, Greenberg M. et al. Executive function in paediatric medulloblastoma: the role of cerebrocerebellar connections. J Neuropsychol 2017; 11 (02) 174-200
  • 24 Moxon-Emre I, Bouffet E, Taylor MD. et al. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. J Clin Oncol 2014; 32 (17) 1760-1768
  • 25 Moxon-Emre I, Taylor MD, Bouffet E. et al. Intellectual outcome in molecular subgroups of medulloblastoma. J Clin Oncol 2016; 34 (34) 4161-4170
  • 26 Duffner PK. The long term effects of chemotherapy on the central nervous system. J Biol 2006; 5 (07) 21
  • 27 Gurney JG, Kadan-Lottick NS, Packer RJ. et al. Childhood Cancer Survivor Study. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003; 97 (03) 663-673
  • 28 Bernier V, Klein O. Late effects of craniospinal irradiation for medulloblastomas in paediatric patients. Neurochirurgie 2018; ;S0028-3770(18)30034-1 DOI: 10.1016/j.neuchi.2018.01.006.
  • 29 Gottardo NG, Gajjar A. Chemotherapy for malignant brain tumors of childhood. J Child Neurol 2008; 23 (10) 1149-1159
  • 30 Packer RJ, Pfister S, Bouffet E. et al. Pediatric low-grade gliomas: implications of the biologic era. Neuro-oncol 2017; 19 (06) 750-761
  • 31 Wallace WHB, Thompson L, Anderson RA. Guideline Development Group. Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance. BMJ 2013; 346: f1190
  • 32 American Academy of Pediatrics Section on Hematology/Oncology Children's Oncology Group. Long-term follow-up care for pediatric cancer survivors. Pediatrics 2009; 123 (03) 906-915
  • 33 Wallace WH, Blacklay A, Eiser C. et al. Late Effects Committee of the United Kingdom Children's Cancer Study Group (UKCCSG). Developing strategies for long term follow up of survivors of childhood cancer. BMJ 2001; 323 (7307): 271-274
  • 34 Heirs M, Suekarran S, Slack R. et al. A systematic review of models of care for the follow-up of childhood cancer survivors. Pediatr Blood Cancer 2013; 60 (03) 351-356
  • 35 Oeffinger KC. Shared care of adult survivors of childhood cancers. Lancet Oncol 2008; 9 (03) 191-193
  • 36 Blaauwbroek R, Tuinier W, Meyboom-de Jong B, Kamps WA, Postma A. Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study. Lancet Oncol 2008; 9 (03) 232-238
  • 37 Arvidson J, Söderhäll S, Eksborg S, Björk O, Kreuger A. Medical follow-up visits in adults 5-25 years after treatment for childhood acute leukaemia, lymphoma or Wilms' tumour. Acta Paediatr 2006; 95 (08) 922-928
  • 38 Absolom K, Greenfield D, Ross R. et al. Predictors of clinic satisfaction among adult survivors of childhood cancer. Eur J Cancer 2006; 42 (10) 1421-1427
  • 39 Granek L, Nathan PC, Rosenberg-Yunger ZRS. et al. Psychological factors impacting transition from paediatric to adult care by childhood cancer survivors. J Cancer Surviv 2012; 6 (03) 260-269
  • 40 Freyer DR. Transition of care for young adult survivors of childhood and adolescent cancer: rationale and approaches. J Clin Oncol 2010; 28 (32) 4810-4818
  • 41 Mouw MS, Wertman EA, Barrington C, Earp JAL. Care transitions in childhood cancer survivorship: providers' perspectives. J Adolesc Young Adult Oncol 2017; 6 (01) 111-119